Multiple novel modalities tasking artificial intelligence based computational pathology applications and integrating other variables, such as risk factors, tumor microenvironment, genomic testing data, laboratory findings, clinical history, and radiology findings, will improve diagnostic consistency and generate a synergistic diagnostic workflow. In this article, we present the concise and contemporary review on the utilization of artificial intelligence in prostate cancer and identify areas for possible future applications.
Keywords: Artificial intelligence; Computational pathology; Machine learning; Prostate cancer; Urologic oncology.
Copyright © 2022 Elsevier Inc. All rights reserved.